Sage Therapeutics
SAGE
#7028
Rank
ยฃ0.40 B
Marketcap
ยฃ6.49
Share price
0.00%
Change (1 day)
2.52%
Change (1 year)

Earnings for Sage Therapeutics (SAGE)

Earnings in 2025 (TTM): -ยฃ0.24 Billion

According to Sage Therapeutics 's latest financial reports the company's current earnings are ยฃ70.41 Million. In 2024 the company made an earning of -ยฃ0.3 Billion, an increase over its 2023 earnings that were of -ยฃ0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sage Therapeutics from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.24 Billion-23.09%
2024 -ยฃ0.3 Billion-26.01%
2023 -ยฃ0.41 Billion1.63%
2022 -ยฃ0.4 Billion16.36%
2021 -ยฃ0.35 Billion-175.55%
2020 ยฃ0.45 B-189.1%
2019 -ยฃ0.51 Billion82.43%
2018 -ยฃ0.28 Billion38.04%
2017 -ยฃ0.21 Billion69.9%
2016 -ยฃ0.12 Billion68.25%
2015 -ยฃ70.71 Million179.48%
2014 -ยฃ25.3 Million84.98%
2013 -ยฃ13.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Regulus Therapeutics
RGLS
-ยฃ35.49 Million-84.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
ยฃ26.68 M-111.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
ยฃ0.38 B-270.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
-ยฃ43.41 Million-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA